Skip to main navigation
Vaxcyte
  • Mission
  • Pipeline
  • Approach
  • About Us
  • Investors & Media
    • Overview
    • Press Releases
    • Events & Presentations
    • Corporate Governance
      • Governance Overview
      • Board of Directors
      • Management
      • Committee Composition
    • Financials & Filings
    • Stock Information
      • Stock Quote & Chart
      • Historic Price Lookup
      • Analyst Coverage
    • Investor Resources
      • Investor FAQs
      • Email Alerts
      • IR Contact
      • Tax Disclosures
  • Careers & Culture
    • Careers
    • Culture
    • Job Listings
Select Page
  • RSS Feeds
  • Email Alerts
  • IR Contact

Events & Presentations

Presentations
Vaxcyte June Investor Presentation
VAX-24 Phase 2 Infant Study Final Results
VAX-24 Phase 2 Infant Study Interim Topline Results
VAX-31 Phase 1/2 Adult Study Results
Vaxcyte VAX-24 Phase 2 65+ Adult Study Results
Upcoming Events
Leerink Partners Therapeutics Forum
Jul 15, 2026
BTIG Virtual Biotechnology Conference
Jul 28, 2026
Past Events
Jun 15, 2026
11:30 AM EDT

Vaxcyte, Inc. Virtual Stockholders Meeting

Feb 24, 2026
4:30 PM EST

Vaxcyte 4Q & FY 2025 Financial Results and Business Update

Jun 12, 2025
11:30 AM EDT

Vaxcyte, Inc. Virtual Stockholders Meeting

Mar 31, 2025
8:00 AM EDT

Vaxcyte VAX-24 Phase 2 Infant Study Results Conference Call

Feb 25, 2025
4:30 PM EST

Vaxcyte 4Q & FY 2024 Financial Results and Business Update

Sep 3, 2024
8:00 AM EDT

Vaxcyte VAX-31 Phase 1/2 Adult Study Results Conference Call

Apr 17, 2023
7:30 AM EDT

Vaxcyte VAX-24 Phase 2 65+ Adult Study Results Conference Call

Oct 24, 2022
8:00 AM EDT

Vaxcyte VAX-24 Phase 1/2 Proof-of-Concept Study Topline Data Call

Vaxcyte

ABOUT US

  • Corporate Profile
  • Management Team
  • Board of Directors
  • Scientific Advisory Board

PIPELINE

  • High-Fidelity Vaccines Engineered to Go the Distance
  • The Rising Consequences of Bacterial Infections
  • Vaccine Candidates Engineered to Overtake Convention
  • Posters & Publications

INVESTORS & MEDIA

  • Overview
  • Press Releases
  • Events & Presentations
  • Corporate Governance
  • Financials & Filings
  • Stock Information
  • Investor Resources
© 2026 Vaxcyte. All rights reserved.
Privacy Policy
Privacy Policy
© 2026 Vaxcyte.   All rights reserved.